Loading PHARMTIVA
Main navigationPHARMTIVA - Pharma Manufacturing, Innovation & Advancement

Get in touch

+91 9878610760parashar993@gmail.com

A Proposed ESG Maturity Assessment Model (EMAM) for Pharmaceutical Manufacturing

Framework, Methodology, Validation Approach

Illustrative pharmaceutical manufacturing and process engineering environment
Illustrative engineering imagery, not a photograph of the named research or an actual project.

Parashar Biswas published this research paper in July 2026. This page presents an overview of the publication and its research focus.

Research focus

  • ESG transformation in pharmaceutical manufacturing
  • Sustainable pharmaceutical engineering
  • Digital manufacturing
  • AI in pharmaceutical development
  • Validation science
  • Pharmaceutical engineering
  • Innovation management

Professional context

Parashar's background spans pharmaceutical engineering, capital-project delivery, manufacturing operations, CQV and technology transfer. His developing interests also include in AI-enabled manufacturing, Digital Twins, Industry 4.0 and sustainable pharmaceutical engineering.

Publication access

The full text, abstract, journal details and DOI are not included here. This is a research overview, not a reproduction of the full paper. Contact Parashar for publication details or access.

Get in touch

Let’s build something together.

A conversation starts here

Let’s build
something together.

Contact PHARMTIVA founder Parashar Biswas.

Founder contact+91 9878610760Founder emailparashar993@gmail.comLocationBengaluru, India